{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:36:39Z","timestamp":1793723799043,"version":"4.6.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jaci.2012.07.047","type":"journal-article","created":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T20:33:54Z","timestamp":1348691634000},"page":"110-116.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":633,"title":["Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma"],"prefix":"10.1016","volume":"131","author":[{"given":"Philippe","family":"Gevaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Calus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Van Zele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Blomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"De Ruyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Bauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hellings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Brusselle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"De Bacquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"van Cauwenberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2012.07.047_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0889-8561(03)00104-8","article-title":"Allergic rhinitis, rhinosinusitis, and asthma: one airway disease","volume":"24","author":"Bachert","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2012.07.047_bib2","unstructured":"GlaxoSmithKline. Asthma in America, a landmark survey. GlaxoSmithKline, 1998. Available at: http:\/\/www.asthmainamerica.com. Accessed November 24, 2011."},{"key":"10.1016\/j.jaci.2012.07.047_bib3","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMra0804579","article-title":"Asthma","volume":"360","author":"Fanta","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2012.07.047_bib4","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2007","volume":"20","author":"Fokkens","year":"2007","journal-title":"Rhinol Suppl"},{"key":"10.1016\/j.jaci.2012.07.047_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1067\/mai.2001.112374","article-title":"Total and specific IgE in nasal polyps is related to local eosinophilic inflammation","volume":"107","author":"Bachert","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl\u00a02","key":"10.1016\/j.jaci.2012.07.047_bib6","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1136\/thorax.55.suppl_2.S79","article-title":"Nasal polyposis, eosinophil dominated inflammation, and allergy","volume":"55","author":"Mygind","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2012.07.047_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1034\/j.1398-9995.2003.00110.x","article-title":"Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis","volume":"58","author":"Gevaert","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2012.07.047_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-9255-6-11","article-title":"Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue","volume":"6","author":"Patou","year":"2009","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.jaci.2012.07.047_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0091-6749(99)70118-1","article-title":"Eosinophilic airway inflammation in nasal polyposis","volume":"104","author":"Lamblin","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.047_bib10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jaci.2004.07.013","article-title":"Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis","volume":"114","author":"Van Zele","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.047_bib11","first-page":"162","article-title":"An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis","volume":"43","author":"Zhang","year":"2005","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2012.07.047_bib12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaci.2010.07.007","article-title":"Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma","volume":"126","author":"Bachert","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.047_bib13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0091-6749(03)70044-X","article-title":"IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma","volume":"111","author":"Bachert","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.047_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1398-9995.2010.02448.x","article-title":"Mucosal tissue polyclonal IgE is functional in response to allergen and SEB","volume":"66","author":"Zhang","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2012.07.047_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1183\/09031936.02.00278102","article-title":"Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma","volume":"20","author":"Buhl","year":"2002","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jaci.2012.07.047_bib16","first-page":"CD003559","article-title":"Anti-IgE for chronic asthma in adults and children","author":"Walker","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2012.07.047_bib17","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.rmed.2009.03.008","article-title":"The use of omalizumab in the treatment of severe allergic asthma: a clinical experience update","volume":"103","author":"Holgate","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2012.07.047_bib18","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.151.5.2623","article-title":"Humanization of an antibody directed against IgE","volume":"151","author":"Presta","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2012.07.047_bib19","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4049\/jimmunol.158.3.1438","article-title":"Down-regulation of Fc(epsilon)RI expression on human basophils during in\u00a0vivo treatment of atopic patients with anti-IgE antibody","volume":"158","author":"MacGlashan","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2012.07.047_bib20","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. US 2010; Available at: http:\/\/www.ginasthma.com. Accessed November 24, 2011."},{"key":"10.1016\/j.jaci.2012.07.047_bib21","first-page":"344","article-title":"Economic implications of chronic sinusitis","volume":"118","author":"Gliklich","year":"1998","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"suppl","key":"10.1016\/j.jaci.2012.07.047_bib22","first-page":"S1","article-title":"Sinusitis: bench to bedside. Current findings, future directions","volume":"116","author":"Kaliner","year":"1997","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2012.07.047_bib23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2500\/ajr.2007.21.3060","article-title":"The role of anti-IgE immunoglobulin therapy in nasal polyposis: a pilot study","volume":"21","author":"Penn","year":"2007","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2012.07.047_bib24","first-page":"158","article-title":"Recalcitrant nasal polyposis: achievement of total remission following treatment with omalizumab","volume":"19","author":"Guglielmo","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.047_bib25","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/thx.2010.152835","article-title":"Efficacy of omalizumab in the treatment of nasal polyps","volume":"66","author":"Vennera Mdel","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2012.07.047_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1378\/chest.10-0128","article-title":"Beneficial effects of treatment with anti-IgE antibodies (omalizumab) in a patient with severe asthma and negative skin-prick test results","volume":"139","author":"van den Berge","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2012.07.047_bib27","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.4049\/jimmunol.158.7.3539","article-title":"Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics","volume":"158","author":"Ying","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2012.07.047_bib28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0091-6749(97)70028-9","article-title":"Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma","volume":"99","author":"Humbert","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.047_bib29","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaci.2009.06.027","article-title":"Unmet needs in severe chronic upper airway disease (SCUAD)","volume":"124","author":"Bousquet","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.047_bib30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.047_bib31","doi-asserted-by":"crossref","first-page":"24083","DOI":"10.1074\/jbc.M703195200","article-title":"Soluble CD23 monomers inhibit and oligomers stimulate IGE synthesis in human B cells","volume":"282","author":"McCloskey","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2012.07.047_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1378\/chest.10-1194","article-title":"Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review","volume":"139","author":"Rodrigo","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2012.07.047_bib33","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jaci.2009.09.021","article-title":"Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma","volume":"124","author":"Lanier","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2012.07.047_bib34","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2222.2009.03214.x","article-title":"Safety and tolerability of omalizumab","volume":"39","author":"Corren","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2012.07.047_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201009-1434OC","article-title":"Presence in sputum of functional dust mite-specific IgE antibodies in intrinsic asthma","volume":"184","author":"Mouthuy","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2012.07.047_bib36","first-page":"183","article-title":"Staging in rhinosinusitus","volume":"31","author":"Lund","year":"1993","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2012.07.047_bib37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.jaci.2012.07.047_bib38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1183\/09031936.04.00064204","article-title":"Relationship between quality of life and clinical status in asthma: a factor analysis","volume":"23","author":"Juniper","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2012.07.047_bib39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00405-003-0691-y","article-title":"Collection of nasal secretions for immunological analysis","volume":"261","author":"Watelet","year":"2004","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674912012948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674912012948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:38:21Z","timestamp":1758789501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674912012948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0091674912012948"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2012.07.047","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717961265.793480804","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717961265.793468876","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717961265.793464041","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717961265.793467940","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2012.07.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}